跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
N-Valeric Acid
首页
药物
N-Valeric Acid
Experimental
Small Molecule
N-Valeric Acid
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
5
H
10
O
2
CAS 编号
109-52-4
UNII ID
GZK92PJM7B
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Polyhydroxyalkanoate and method of producing same, and w-(2-thienylsulfanyl) alkanoic acid and method of producing same
US 2002164726 A1
申请人: KENMOKU TAKASHI
优先权: 2001
US
4 件公开
N-aryl-carbamic acid ester-derived and valeric acid ester-derived cross-linkers and conjugates, and methods for their synthesis and use
US 6887952 B1
申请人: BIOSITE INC
优先权: 2004
US
4 件公开
Pharmaceutical composition comprising (1r,4r)-6-fluoro-N, N-dimethyl-4-phenyl-4,9-dihydro-3H-spiro[cyclohexane-1,1-pyrano[3,4,b]indol]-4-amine and an anticonvulsant
US 9345689 B2
申请人: GRUENENTHAL GMBH
优先权: 2013
CN
US
3 件公开
MOSQUITO REPELLENT SOLUTION, PREPARATION METHOD AND USE THEREOF
US 2012045525 A1
申请人: MA JIANYI
优先权: 2008
US
Paraquat hapten, paraquat complete antigen and preparation method of paraquat hapten and paraquat complete antigen
CN 103130712 A
申请人: INST HYGIENE & ENVIRONMETNAL MEDICINE ACADEMY MILITARY MEDICAL SCIENCES
优先权: 2011
CN
Method for preparing high-purity butyphthalide
CN 110003154 A
申请人: HEBEI ZHI HENG PHARMACY TECH CO LTD
优先权: 2019
CN
Preparation method of (S)-2-((9H-fluoren-9-methoxycarbonyl)methylamino)-5-amino-5-oxovaleric acid
CN 112174854 A
申请人: SHANGHAI JIFENG BIOTECHNOLOGY CO LTD
优先权: 2020
CN
Antibiotic compounds, formulations and methods of use
CN 118871454 A
申请人: UNIV LEIDEN
优先权: 2022
CN
Non-starch avicennia marina total polysaccharide, preparation method thereof and application of non-starch avicennia marina total polysaccharide as intestinal prebiotics
CN 114524886 A
申请人: GUANGXI TRADITIONAL CHINESE MEDICINE UNIV
优先权: 2022
CN
Synthesis process of 5-n-propyl hydantoin
CN 116715635 A
申请人: HEBEI XINTAOYUAN MEDICINE TECH CO LTD
优先权: 2023
CN
第 1 / 2 页
上一页
下一页
药物
反馈